Skip to Content

MYLAN 2036 MYLAN 2036 (Topiramate (sprinkle) 25 mg)

Pill imprint MYLAN 2036 MYLAN 2036 has been identified as Topiramate (sprinkle) 25 mg.

Topiramate is used in the treatment of obesity; migraine prevention; fibromyalgia; bipolar disorder; diabetic peripheral neuropathy (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Topiramate (sprinkle) 25 mg MYLAN 2036 MYLAN 2036
Discount Card Promo
Topiramate (sprinkle)
MYLAN 2036 MYLAN 2036
25 mg
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Mylan Pharmaceuticals Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.